These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 80488)

  • 41. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measurement of blood heparin levels--variation in results with assay method.
    Juhan-Vague I; Riera H; Aillaud MF; Verdet D; Sambuc R
    Thromb Haemost; 1982 Jun; 47(3):295. PubMed ID: 7112503
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical value of a new method of therapeutic control of heparin].
    Pizzuto J; Garcia S; de la Paz Reyna M; Morales MR; Avilés A; Zavala B; Ponce L; Gaos C
    Arch Inst Cardiol Mex; 1978; 48(2):373-86. PubMed ID: 666447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin and protamine therapy.
    Arén C
    Semin Thorac Cardiovasc Surg; 1990 Oct; 2(4):364-72. PubMed ID: 2091796
    [No Abstract]   [Full Text] [Related]  

  • 47. [Determination of activated recalcification time in thrombocyte-poor plasma].
    Kuhfahl E
    Z Med Lab Diagn; 1986; 27(8):451-7. PubMed ID: 3564626
    [No Abstract]   [Full Text] [Related]  

  • 48. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 52. Variability in heparin sensitivity according to method.
    Scully MF; Decousus HA; Ellis V; Kakkar VV
    Br J Haematol; 1987 Jul; 66(3):434. PubMed ID: 3620364
    [No Abstract]   [Full Text] [Related]  

  • 53. [A simple method for the quantitative determination of heparin by titration with protamine].
    KALLER H
    Arch Int Pharmacodyn Ther; 1954 Sep; 99(2):163-74. PubMed ID: 13229427
    [No Abstract]   [Full Text] [Related]  

  • 54. Sodium heparin determination: comparison of an instrumental method with the USP method.
    Reed M; Wilson G; Davenport W; Schmitz T; Klamrzynski M
    J Pharm Sci; 1974 Sep; 63(9):1455-7. PubMed ID: 4427272
    [No Abstract]   [Full Text] [Related]  

  • 55. [Protamine and ethanol tests in pregnancy and puerperium].
    Uszyńska-Folejewska R; Uszyński M; Soszka T
    Ginekol Pol; 1973 Feb; 44(2):135-9. PubMed ID: 4689597
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the effect of certain basic proteins (protamine, protein C and papain) in experimental peritonitis].
    BRANCATO U
    Riv Patol Clin; 1959 Dec; 14():947-50. PubMed ID: 13803831
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of hemodilution, pH, and protamine on lidocaine plasma protein binding and red blood-cell uptake in vitro.
    Remmel RP; Copa AK; Angaran DM
    Pharm Res; 1991 Jan; 8(1):127-30. PubMed ID: 1901648
    [No Abstract]   [Full Text] [Related]  

  • 58. [Method of determination of protamine titre].
    Kriazhev LN; Timofeev GA
    Lab Delo; 1978; (7):434-5. PubMed ID: 80488
    [No Abstract]   [Full Text] [Related]  

  • 59. [Degradation of protamine and protamine-heparin complexes by proteolytic enzymes of blood serum and serum euglobulin fractions].
    Roszkowska W; Worowski K; Ostrowska H
    Acta Haematol Pol; 1984; 15(1-2):43-7. PubMed ID: 6516712
    [No Abstract]   [Full Text] [Related]  

  • 60. Monitoring heparin anticoagulation and its neutralization.
    Jobes DR; Schwartz AJ; Ellison N; Andrews R; Ruffini RA; Ruffini JJ
    Ann Thorac Surg; 1981 Feb; 31(2):161-6. PubMed ID: 6970019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.